Department of Plastic and Reconstructive Surgery, Saint Barnabas Medical Center, 94 Old Short Hills Rd, Livingston, NJ, 07039, USA.
Aesthetic Plast Surg. 2018 Aug;42(4):1024-1032. doi: 10.1007/s00266-018-1129-7. Epub 2018 Apr 18.
Festoons and malar bags present a particular challenge to the plastic surgeon and commonly persist after the traditional lower blepharoplasty. They are more common than we think and a trained eye will be able to recognize them. Lower blepharoplasty in these patients requires addressing the lid-cheek junction and midcheek using additional techniques such as orbicularis retaining ligament (ORL) and zygomaticocutaneous ligament (ZCL) release, midface lift, microsuction, or even direct excision (Kpodzo e al. in Aesthet Surg J 34(2):235-248, 2014; Goldberg et al. in Plast Reconstr Surg 115(5):1395-1402, 2005; Mendelson et al. in Plast Reconstr Surg 110(3):885-896, 2002). The goal in these patients is to restore a smooth contour from the lower eyelid to the cheek. The review of literature shows the need for more than one surgery for treatment of the festoons (Furnas in Plast Reconstr Surg 61(4):540-546, 1978). One of the reasons WHY these cases are so challenging is that the festoons tend to persist even after surgical treatment. As Furnas said, "Malar mounds have acquired some notoriety for their persistence in the face of surgical efforts to remove them" (Furnas in Clin Plast Surg 20(2):367-385, 1993). This could be due to different etiology between acquired and congenital festoons. There are currently no cases of congenital festoons described in the literature. In the last 10 years, we have treated a total of 59 patients with festoons or malar mounds. We used the terminology of festoon for acquired cases and malar mound for congenital ones (Kpodzo et al. 2014). We were successful with treating 56 patients who developed acquired festoons later on in life; however, three cases required an additional treatment to improve residual puffiness that they had after the first operation. From the above findings, we hypothesized that there should be something common in patients with congenital festoons or malar mounds which are different from acquired festoons. All of these three patients had one thing in common, and that was a history of puffiness of the prezygomatic space since childhood. Each of these patients expressed that these conditions have been present since a young age but became worse with aging over time. To date, there are no descriptions of the cause or treatment for congenital festoons. Here, we present the first case series of three patients with congenital festoons. We discuss the possible etiology of congenital festoons, the physical exam, and the surgical approaches.
We performed a retrospective review of 59 patients who had surgical correction of festoons in the past 10 years, three of which were presented since childhood. In this paper, we will discuss the pathophysiology and the surgical treatments for congenital festoons. Only patients with festoons present since birth were included. The first two cases were treated with a subciliary blepharoplasty with release of the orbicularis retaining and zygomaticocutaneous ligaments and midface lift with canthopexy and orbicularis muscle suspension. The third case had a subciliary lower blepharoplasty approach, skin, and muscle flap and direct excision of the fat through the orbicularis from the subcutaneous space. In addition, each patient required further treatments to address supra-orbicularis fat by various methods.
All patients with acquired festoons had successful results with one operation by subciliary skin muscle flap, release of the ORL and ZCL, midface lift, and muscle suspension. All three patients with congenital festoons had residual puffiness that required surgical and non-surgical treatments. There were no complications. Our first case required three surgical treatments for complete correction. The second and third cases required Kybella injections after their initial surgical treatments. The specimen of the first patient, Fig. 10, who had direct excision, showed localized fat collection immediately under the skin and above the orbicularis oculi muscle.
Correction of congenital festoons or malar mounds requires a combination of subciliary lower blepharoplasty with skin muscle flap, midface lift, and orbicularis muscle suspension, as well as addressing the supra-orbicularis fat via direct excision, off-label Kybella injection or liposuction.
This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
褶和颊袋对整形外科医生来说是一个特别的挑战,并且通常在传统的下眼睑成形术后仍然存在。它们比我们想象的更常见,经过训练的眼睛将能够识别它们。对于这些患者,下眼睑成形术需要解决睑颊交界处和中颊部的问题,使用额外的技术,如眼轮匝肌保留韧带(ORL)和颧颊韧带(ZCL)释放、中面部提升、微吸或甚至直接切除(Kpodzo 等人,Aesthet Surg J 34(2):235-248, 2014;Goldberg 等人,Plast Reconstr Surg 115(5):1395-1402, 2005;Mendelson 等人,Plast Reconstr Surg 110(3):885-896, 2002)。这些患者的目标是从下眼睑到脸颊恢复光滑的轮廓。文献综述表明,褶的治疗需要不止一次手术(Furnas,Plast Reconstr Surg 61(4):540-546, 1978)。这些病例如此具有挑战性的原因之一是,即使经过手术治疗,褶也往往仍然存在。正如 Furnas 所说,“颊丘因其有去除它们的外科努力的情况下仍然存在而声名狼藉”(Furnas,Clin Plast Surg 20(2):367-385, 1993)。这可能是由于获得性和先天性褶的病因不同。目前文献中没有先天性褶的病例描述。在过去的 10 年中,我们总共治疗了 59 例褶或颊袋患者。我们将获得性病例称为褶,先天性病例称为颊袋(Kpodzo 等人,2014)。我们成功地治疗了 56 例后来发展为获得性褶的患者;然而,有 3 例需要额外的治疗来改善他们第一次手术后仍存在的残留肿胀。从上述发现中,我们假设先天性褶或颊袋患者与获得性褶患者之间应该存在一些共同点。这三个患者都有一个共同点,即自童年起就存在颧前间隙的肿胀。每个患者都表示这些情况从年轻时就存在,但随着年龄的增长,情况变得越来越糟。迄今为止,尚无先天性褶的病因或治疗方法的描述。在这里,我们报告了三例先天性褶的首例病例系列。我们讨论了先天性褶的可能病因、体格检查和手术方法。
我们对过去 10 年中接受褶手术矫正的 59 名患者进行了回顾性分析,其中 3 名患者自童年起就存在褶。在本文中,我们将讨论先天性褶的病理生理学和手术治疗。仅包括自出生以来就存在褶的患者。前两个病例采用下眼睑切开术,释放眼轮匝肌保留韧带和颧颊韧带,并进行中面部提升、canthopexy 和眼轮匝肌悬吊术。第三个病例采用下眼睑切开术、皮肤和肌肉瓣,通过眼轮匝肌从皮下空间直接切除脂肪。此外,每个患者都需要通过各种方法进一步治疗来解决眶上脂肪问题。
所有获得性褶患者均通过下眼睑皮肤肌肉瓣、ORL 和 ZCL 释放、中面部提升和肌肉悬吊术一次性手术获得成功结果。所有 3 例先天性褶患者均有残留肿胀,需要手术和非手术治疗。无并发症。我们的第一个病例需要进行三次手术才能完全矫正。第二例和第三例患者在初始手术治疗后需要注射 Kybella。第一个患者(图 10)的标本显示,直接切除后,皮肤和眼轮匝肌上方的皮下立即出现局部脂肪堆积。
先天性褶或颊袋的矫正需要结合下眼睑切开术、皮肤肌肉瓣、中面部提升和眼轮匝肌悬吊术,以及通过直接切除、非标记 Kybella 注射或吸脂术来解决眶上脂肪问题。
证据水平 IV:本杂志要求作者为每篇文章分配一个证据水平。有关这些循证医学评级的详细描述,请参考目录或在线作者指南 www.springer.com/00266 。